A closed biological production process reduces risks in drug manufacturing by diminishing the chance of contamination. This is true for mAbs, vaccines, bioconjugates, cell therapies, and gene therapies. Incorporating these technologies early in production makes scaling up easier.

With industry-leading turnaround times, we deliver high performing, inert, and low E&L solutions for single-use and full-scale processes in upstream, downstream, fill/finish, and oligonucleotide applications. Our comprehensive set of bag solutions, motion bioreactor bags, mixing systems, and microcarrier separation systems meets emerging requirements of fast-growing, bioprocessing applications. We can customize process solutions and deliver with speed to meet tight development timelines. We also provide a complete line of accessories, tubing, fittings, and related products to fill any company's bioprocessing needs.